Australia/New Zealand
Cancer
Instruments
Reagents
- AFP
- CA 125
- CA 15-3
- CA 19-9 XR
- CA 19-9
- CEA
- CYFRA 21-1
- Free PSA
- HE-4
- ProGRP
- SCC
- Total PSA
Grayed text indicates a product in research or development.
Not all assays are available in all countries.
Abbott offers an array of in-vitro diagnostic tests for the detection and monitoring of cancerous conditions in patients.
In men, prostate specific antigen, or PSA, testing helps aid in the detection of prostate cancer and to aid in the management of prostate cancer patients.
CA 15-3™** testing aids in the management of Stage II and III breast cancer patients. Abbott also offers the CA 125™** test to aid in monitoring response to therapy for patients with epithelial ovarian cancer.
** CA 15-3™, CA 19-9™ and CA 125™ are trademarks of Fujirebio Diagnostics, Inc.